Clinical Trial

Hybrid Closed-Loop System in Neurosurgical Perioperative Hyperglycemia: An Open RCT

Recruiting
View on ClinicalTrials.gov →
Summary
In this study, we plan to use an open-source hybrid closed-loop artificial pancreas system and a combination of a traditional insulin pump and continuous glucose monitoring (CGM) respectively to conduct short-term intensive insulin treatment for patients with type 2 diabetes mellitus (T2DM) during the perioperative period who are hospitalized in the Department of Neurosurgery of Shanxi Bethune Hospital. By comparing the blood glucose control status of patients under different intensive insulin treatment regimens and other clinical indicators such as postoperative complications, we will comprehensively evaluate the clinical efficacy and safety of the hybrid closed-loop artificial pancreas system.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-27.
Trial Details
NCT Number NCT06909071
Lead Sponsor Shanxi Bethune Hospital
Conditions T2DM Patients With Traumatic Brain Injury
Enrollment 40 participants
Start Date 2025-04-15
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-23